AstraZeneca Chief Executive Pascal Soriot is looking at ways to boost the U.K. drug maker's share price after fighting off Pfizer, including forming cancer-treatment partnerships with rivals and making its own acquisitions.
from WSJ.com: US Business http://ift.tt/1vubvhQ
via IFTTT
from WSJ.com: US Business http://ift.tt/1vubvhQ
via IFTTT
No comments:
Post a Comment